A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation. A report of the United States FK506 study group

Transplantation

Volumn 66, Issue 4, 1998, Pages 493-499

  Wiesner, Russell H ^a   Busttil, R W ^b   McDiarmid, S ^b   Klintmalm, G B ^c   Goldstein, R ^c   Miller, C M ^d   Schwartz, M ^d   Shaw, B W ^e   Roberts, J P ^f   Herbert, M F ^f   Esquivel, C O ^g   Nakazato, P ^g   Krom, R A F ^a   Kalayoglu, M ^h   D'Alessandro, A M ^h   Marsh, J W ⁱ   Peters, M G ⁱ   Burdick, J ^j   Klein, A ^j   Lewis, W D ^k   Jenkins, R ^k   Thistlethwaite, J R ^l   Edmod, J C ^l   Gadgil, S ^m   Facklam, D P ^m   more..

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^h UNIVERSITY OF WISCONSIN MADISON   (United States)

ⁱ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j JOHNS HOPKINS HOSPITAL   (United States)

^k New England Deaconess Hospital   (United Kingdom)

^l UNIVERSITY OF CHICAGO   (United States)

^m Fujisawa USA Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; LYMPHOBLAST ANTIBODY; OKT 3; PREDNISONE; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GRAFT INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; LIVER FUNCTION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REOPERATION; SURVIVAL RATE; TACROLIMUS; TIME FACTORS;

EID: 0032572809     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808270-00014     Document Type: Article

References (19)

1. Kino T, Hatanaka H, Hashimoto M, et al. FK506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physiochemical and biological characteristics. J Antibiot (Tokyo) 1987; 40: 1249.
2. Kino T, Hatanaka H, Miyata S, et al. FK506, a novel immunosuppressant isolated from a Streptomyces. I. Immunosuppressive effect of FK506 in vitro. J Antibiot (Tokyo) 1987; 40: 1256.
3. Starzl TE, Todo S, Fung J, et al. FK506 for human liver, kidney, and pancreas transplantation. Lancet 1989; 2: 1000.
4. Migita K, Eguchi K, Kawabe Y, Tsukada T, Mizokami A, Nagataki S. FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. J Clin Invest 1995; 96: 727.
5. Fung JJ, Eliasziw M, Todo S, et al. The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg 1996; 183: 117.
6. Neuhaus P, Blumhardt G, Bechstein WO, et al. Comparison of FK506 and cyclosporine-based immunosuppression in primary orthotopic liver transplantation: a single center experience. Transplantation 1995; 59: 31.
7. US Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110.
8. McDiarmid SV, Busuttil RW, Ascher NL, et al. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Transplantation 1995; 59(4): 530.
9. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423.
10. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997; 63: 977.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
12. Cho YW, Terasaki PI. Long-term survival. In: Terasaki PI, ed. Clinical transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1988.
13. Todo S, Fung JJ, Starzl TE, et al. Single center experience with primary orthotopic liver transplantation with FK506 immunosuppression. Ann Surg 1994; 220: 297.
14. Abu-Elmagd K, Fung J, Todo S, et al. The current status of hepatic transplantation at the University of Pittsburgh. In: Cecka JM, Terasaki PI, eds. Clinical transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1995: 145.
15. Gjertson DW, Cecka JM, Terasaki PI. The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation 1995; 60: 1384.
16. Katznelson S, Cecka JM. Immunosuppressive regimens and their effects on renal allograft outcome. In: Cecka JM, Terasaki PI, eds. Clinical transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1996; 361.
17. Flamm SL, Marcos A, Jenkins RL, Lewis WD, Gordon FD. Tacrolimus is associated with decreased survival in patients undergoing liver transplantation with chronic hepatitis C infection. ASTP Annual Meeting 1996; Abstracts-On-Disk (K-LI-087).
18. Reyes J, Tzakis A, Green B, et al. Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. Transplant Proc 1991; 23: 3044.
19. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133: 173.